Keyphrases
Atopic Dermatitis
100%
Indonesia
40%
Methotrexate
31%
Surabaya
25%
COVID-19
24%
Balb C Mice
24%
Psoriasis
24%
Skin Prick Test
23%
Healthcare Workers
21%
Psoriasis Vulgaris
20%
Meta-analysis
17%
House Dust Mite
17%
Moderate-to-severe Psoriasis
17%
House Dust Mite Allergen
16%
Allergen
16%
Systematic Meta-analysis
15%
Tinea Capitis
15%
Vitamin D Supplementation
15%
Scratching Behavior
15%
Skin Barrier Function
15%
Ceramide
15%
Severity of Atopic Dermatitis
15%
Indonesian Batik
15%
Batik Worker
15%
Occupational Contact Dermatitis
15%
Tertiary Hospital
15%
Acidity
14%
Psoriasis Therapy
14%
Transepidermal Water Loss
14%
Hand Dermatitis
13%
Academic Hospital
13%
Clinical Improvement
12%
Disease Severity
12%
Venereology
12%
Trichoscopy
11%
Vitamin D
11%
Palmar
11%
SCORing Atopic Dermatitis (SCORAD)
11%
Severity Index
11%
Area Index
11%
Psoriasis Area
11%
Psoriasis Severity
11%
Fungal Infection
11%
Skin Barrier
11%
Serum IgE
10%
GloVe
9%
Adult Patients
9%
COVID-19 Pandemic
9%
Isolation Ward
9%
Infections in children
9%
Pharmacology, Toxicology and Pharmaceutical Science
Atopic Dermatitis
78%
Methotrexate
31%
Diseases
26%
Psoriasis
25%
Allergen
25%
Retrospective Study
24%
Dermatitis
21%
Vitamin D
15%
Occupational Eczema
15%
Coronavirinae
15%
Immunoglobulin E
14%
Urticaria
10%
Skin Defect
10%
Disease Severity
10%
Clinical Trial
10%
Psoriasis Vulgaris
10%
Side Effect
9%
Fusarium solani
7%
Cornea Edema
7%
Hydration
7%
Janus Kinase Inhibitor
7%
Randomized Controlled Trial
7%
Dermatophagoides
7%
Ciclosporin
7%
Phenyltoloxamine Citrate
7%
Shrimp
7%
Dairy Cattle
7%
Chickenpox
7%
Monkeypox
7%
Polidocanol
7%
Ceramide
7%
Skin Pruritus
7%
Tinea pedis
7%
Sunscreen
7%
Aloe Vera
7%
Sweet Potato
7%
Lopinavir Plus Ritonavir
7%
Infection
7%
Mycosis
7%
Egg White
7%
Dermatophyte
5%
Pruritus
5%
Medicine and Dentistry
Psoriasis
31%
Methotrexate
23%
Mycosis
21%
Infection
17%
COVID-19
16%
Tinea Capitis
15%
Clinical Trial
15%
Diseases
11%
Urticaria
9%
Venereology
9%
Dermatology
9%
Atopic Dermatitis
9%
Itraconazole
9%
Retrospective Study
8%
Psoriasis Area and Severity Index
8%
Ceramide
7%
Microsporum
7%
Athlete's Foot
7%
Janus Kinase Inhibitor
7%
Occupational Eczema
7%
Phaeohyphomycosis
7%
Monkeypox
7%
Chickenpox
7%
Cyclosporine
7%
Centella asiatica
7%
Lopinavir/Ritonavir
7%
Dysbiosis
7%
Cohort Effect
7%
Dermatitis
7%
Basidiobolomycosis
7%
Scalp
7%
Pediatrics Patient
7%
Gut Microbiota
7%
Phototherapy
7%
Skin Type
7%
Patient with Diabetes
7%
Diagnosis
7%
Mucormycosis
7%
Probiotics
7%
Back
6%
Dermatophyte
5%
Disease Predisposition
5%
Arm
5%